UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 4, 2003
SURGICARE, INC.
(Exact name of registrant as specified in its charter)
Commission File No.: 001-16587
Delaware 58-1597246
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)
12727 Kimberley Lane, Suite 200
Houston, Texas 77024
(Address of principal executive offices) (Zip Code)
(713) 973-6675
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
EXPLANATORY NOTE
This Amendment to Form 8-K is being filed for the sole purpose of filing
the letter dated July 31, 2003, from Weinstein Spira & Company , P.C. to the
Securities and Exchange Commission, relating to the Registrant's Item 4
disclosure in the Form 8-K filed August 1, 2003. Registrant received a copy of
that letter on August 1, 2003 after filing.
Item 7. Financial Statements and Exhibits.
(b) Exhibits.
The following Exhibit is filed herewith:
Exhibit No. Description
----------- -----------
16.1 Letter to the Securities and Exchange Commission from
Weinstein Spira & Company, P.C., dated July 31, 2003,
regarding Item 4 to the Registrant's Form 8-K filed August 1,
2003.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Dated: August 4, 2003
SURGICARE, INC.
By /s/ Phillip C. Scott
------------------------------------------------------------------------
Phillip C. Scott
Chief Financial Officer
EXHIBIT INDEX
Exhibit No. Description
---------- -----------
16.1 Letter to the Securities and Exchange Commission from Weinstein
Spira & Company, P.C., dated July 31, 2003, regarding Item 4 to
the Registrant's Form 8-K filed August 1, 2003.